Invivyd (IVVD) Revenue & Revenue Breakdown
Invivyd Revenue Highlights
00
Invivyd Revenue by Period
Invivyd Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | - |
Invivyd Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | - | -100.00% |
2023-12-31 | $3.02M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-09-30 | - | - |
Invivyd Revenue Breakdown
Invivyd Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Jun 24 |
---|---|
Product | $2.26M |
Latest
Invivyd Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RGNX | REGENXBIO | $90.24M | $24.20M |
RXRX | Recursion Pharmaceuticals | $44.58M | $14.42M |
EXAI | Exscientia | $24.96M | $5.29M |
KRON | Kronos Bio | $6.29M | $2.37M |
GBIO | Generation Bio | $5.90M | $4.09M |
ABEO | Abeona Therapeutics | $3.50M | - |
MGTA | Dianthus Therapeutics | $314.00K | $72.00K |
ANEB | Anebulo Pharmaceuticals | - | - |
BDTX | Black Diamond Therapeutics | - | - |
CCCC | C4 Therapeutics | - | - |
ERAS | Erasca | - | - |
PASG | Passage Bio | - | - |
APVO | Aptevo Therapeutics | - | - |
UBX | Unity Bio | - | - |
EWTX | Edgewise Therapeutics | - | - |
IVVD | Invivyd | - | - |
AVIR | Atea Pharmaceuticals | - | - |